Disease/Infection News

RSS

Study reveals humans are passing antibiotic resistance to wildlife in protected areas

A team of Virginia Tech researchers has discovered that humans are passing antibiotic resistance to wildlife, especially in protected areas where numbers of humans are limited.

25 Apr 2013

New information on mitigating spread of infection from flu viruses

Pandemic flu continues to threaten public health, especially in the wake of the recent emergence of an H7N9 low pathogenic avian influenza strain in humans.

25 Apr 2013

H7N9 flu virus found to transmit from birds to humans but not person-to-person

Scientists in China have confirmed for the first time that the influenza A H7N9 virus has transmitted from birds—specifically, chicken at a wet poultry market—to humans, according to an Article published Online First in The Lancet.

25 Apr 2013

To avoid difficulties experienced during SARS epidemic, China must remain transparent in H7N9 efforts

"On this 10th anniversary of China's April 2003 admission that the SARS virus had spread across that country ... Beijing finds itself once again in a terrible position via-a-vis the microbial and geopolitical worlds," Laurie Garrett, a senior fellow for global health at the Council on Foreign Relations, writes in a Foreign Policy opinion piece, noting the emergence of a new strain of bird flu, H7N9, in the country.

25 Apr 2013

Three steps to eliminating NTDs

In a post on the PLoS "Speaking of Medicine" blog, PLoS Neglected Tropical Diseases (NTDs) editor-in-chief Peter Hotez, dean of the National School of Tropical Medicine at Baylor College of Medicine and president of the Sabin Vaccine Institute and Texas Children's Hospital Center for Vaccine Development, reviews progress being made toward the elimination of NTDs through mass drug administration and other efforts.

25 Apr 2013

UNITAID, Medicines Patent Pool work to improve access to medicines in developing world

Devex features a sponsored interview with Dennis Broun, executive director of UNITAID, which uses innovative financing and "its understanding of how to address market shortcomings to improve access to quality-assured treatment and diagnostics for HIV and AIDS, tuberculosis and malaria patients in low-income countries."

25 Apr 2013

Malaria approaches must be adjusted to account for local contexts, 'changing realities'

Noting "April 25 marks World Malaria Day, an opportunity for those who work to defeat the illness to review progress and renew commitments," Laurence Slutsker and Patrick Kachur of the CDC's Division of Parasitic Diseases and Malaria, write in a Malaria Journal opinion piece, "After a decade of steady success, this year's commemoration of the date is also an opportunity to reconsider current approaches and assess the state of the science needed to keep pace in the global effort to combat malaria."

25 Apr 2013

Fighting schistosomiasis would help reduce HIV incidence, researchers say

"The transmission of HIV in sub-Saharan Africa could be slashed if efforts are made to combat the spread of the waterborne disease schistosomiasis by providing clean water, sanitation and health education, a study reports," SciDev.Net writes.

25 Apr 2013

Vertex presents data of telaprevir Phase 3b CONCISE study in people with genotype 1 chronic HCV

Vertex Pharmaceuticals Incorporated today announced new data from an interim analysis of the exploratory global Phase 3b CONCISE study evaluating the potential to shorten total treatment with telaprevir combination therapy to 12 weeks in certain people with genotype 1 chronic hepatitis C virus infection who have the IL28B CC genotype.

25 Apr 2013

Phase I/II data on Baxter's Lyme disease candidate vaccine presented at NFID conference

Baxter International Inc. today announced Phase I/II data evaluating the safety and immunogenicity of its investigational Lyme disease candidate vaccine during the National Foundation for Infectious Diseases 16th Annual Conference on Vaccine Research in Baltimore, Md.

From Baxter International Inc. 25 Apr 2013

LINCC Initiative to provide charitable contribution to 16 organizations to support individuals with HIV/AIDS

Janssen Therapeutics, Division of Janssen Products, LP, today announced the 16 organizations that will receive a charitable contribution from its Linking In-Need Communities to Care Initiative.

25 Apr 2013

FDA announces public-private partnership to identify counterfeit anti-malarial medicines with CD-3

The U.S. Food and Drug Administration today announced a public-private partnership to help identify counterfeit or substandard anti-malarial medicines, including falsified products, with the deployment of the FDA-developed Counterfeit Detection Device, called CD-3.

25 Apr 2013

WHO highlights threat of antimalarial drug resistance in Greater Mekong subregion

On World Malaria Day, 25 April, WHO recognizes significant accomplishments in preventing and controlling malaria, including in high-burden countries in sub-Saharan Africa, but highlights the threat of antimalarial drug resistance in south-east Asia's Greater Mekong subregion, where an emergency response is now being launched.

25 Apr 2013

Janssen submits Marketing Authorization Application to EMA for simeprevir approval

Medivir AB today announces that Janssen-Cilag International NV today has submitted a Marketing Authorization Application to the European Medicines Agency seeking approval for simeprevir (TMC435).

25 Apr 2013

Dietary substitution of saturated fats enriched in MCT prevents liver disease

Scientists at the Arkansas Children's Nutrition Center, a U.S. Department of Agriculture Agricultural Research Service Human Nutrition Research Center at the University of Arkansas for Medical Sciences, led by Dr. Martin Ronis have determined that dietary substitution of saturated fats enriched in medium chain triglycerides (MCT) for polyunsaturated fat prevents the development of nonalcoholic fatty liver disease (NAFLD).

25 Apr 2013

Sofosbuvir is safer than interferon for hepatitis C patients, say scientists

A new drug is offering dramatic cure rates for hepatitis C patients with two subtypes of the infection -- genotype 2 and 3, say a team of scientists led by Weill Cornell Medical College researchers.

25 Apr 2013

Targeted screening for chronic hepatitis C virus infection is cost-effective, say researchers

Researchers at the University of Cincinnati have found that targeted screening for populations with a higher estimated prevalence for hepatitis C may be cost-effective.

25 Apr 2013

WHO research team still unsure of H7N9 transmission routes

The WHO "has only a limited understanding of a deadly new form of avian flu that has killed 20 people and infected more than a hundred others, a team of researchers said on Monday, leaving unclear how the disease spreads and how virulent it could become," the Wall Street Journal reports.

24 Apr 2013

Supreme Court justices hear arguments in case challenging anti-prostitution pledge

"Supreme Court justices appeared divided on Monday as they considered a challenge to a law requiring non-profit organizations to adopt an anti-prostitution policy in order to obtain federal funding for HIV/AIDS programs abroad," Reuters reports (Hurley, 4/22).

24 Apr 2013

Research maps risk factors for transmission of animal brucellosis, BTB to humans

A new study at the Institute of Tropical Medicine in Antwerp analyses the impact of animal brucellosis and bovine tuberculosis on animals and people in urban, peri-urban and rural Niger.

24 Apr 2013

Disease/Infection News

Study reveals humans are passing antibiotic resistance to wildlife in protected areas

New information on mitigating spread of infection from flu viruses

H7N9 flu virus found to transmit from birds to humans but not person-to-person

To avoid difficulties experienced during SARS epidemic, China must remain transparent in H7N9 efforts

Three steps to eliminating NTDs

UNITAID, Medicines Patent Pool work to improve access to medicines in developing world

Malaria approaches must be adjusted to account for local contexts, 'changing realities'

Fighting schistosomiasis would help reduce HIV incidence, researchers say

Vertex presents data of telaprevir Phase 3b CONCISE study in people with genotype 1 chronic HCV

Phase I/II data on Baxter's Lyme disease candidate vaccine presented at NFID conference

LINCC Initiative to provide charitable contribution to 16 organizations to support individuals with HIV/AIDS

FDA announces public-private partnership to identify counterfeit anti-malarial medicines with CD-3

WHO highlights threat of antimalarial drug resistance in Greater Mekong subregion

Janssen submits Marketing Authorization Application to EMA for simeprevir approval

Dietary substitution of saturated fats enriched in MCT prevents liver disease

Sofosbuvir is safer than interferon for hepatitis C patients, say scientists

Targeted screening for chronic hepatitis C virus infection is cost-effective, say researchers

WHO research team still unsure of H7N9 transmission routes

Supreme Court justices hear arguments in case challenging anti-prostitution pledge

Research maps risk factors for transmission of animal brucellosis, BTB to humans

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Shaping the future of lab automation through AI and robotics

Latest News